Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
14.42
+0.02 (0.14%)
At close: Sep 29, 2026, 4:00 PM EDT
14.70
+0.28 (1.94%)
After-hours: Sep 29, 2026, 7:30 PM EDT
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $2.05 billion as of September 29, 2026. Its market cap has increased by 92.37% in one year.
Market Cap
2.05B
Enterprise Value
1.74B
1-Year Change
92.37%
Ranking
Category
Stock Price
$14.42
ChartMarket Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $2.05B, an increase of 2,317.37%. That is a compound annual growth rate of 53.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 2.05B | 27.97% |
| Dec 31, 2025 | 1.61B | 336.04% |
| Dec 31, 2024 | 368.19M | 330.28% |
| Dec 29, 2023 | 85.57M | -26.01% |
| Dec 30, 2022 | 115.65M | 472.04% |
| Dec 31, 2021 | 20.22M | -54.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nektar Therapeutics | 2.06B |
| Vericel | 2.06B |
| Palvella Therapeutics | 2.01B |
| Biohaven | 2.00B |
| UroGen Pharma | 2.00B |
| Agios Pharmaceuticals | 2.00B |
| Sarepta Therapeutics | 1.99B |
| Recursion Pharmaceuticals | 1.98B |